http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 10 Jul 2026 20:17:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+08++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26758291.html si-local-file:///var/storage/secattach/20260710/26758291.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+08++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26758291.html Fri, 10 Jul 2026 20:17:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+08++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26758291.html si-local-file:///var/storage/secattach/20260710/26758291.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+08++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26758291.html Fri, 10 Jul 2026 20:17:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jun+26++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26743159.html si-local-file:///var/storage/secattach/20260707/26743159.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jun+26++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26743159.html Tue, 07 Jul 2026 22:04:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jun+26++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26743159.html si-local-file:///var/storage/secattach/20260707/26743159.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jun+26++Filed+by%3A+HARARI+ELIYAHOU+ET+AL/26743159.html Tue, 07 Jul 2026 22:04:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727855.html si-local-file:///var/storage/secattach/20260702/26727855.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727855.html Thu, 02 Jul 2026 16:13:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727855.html si-local-file:///var/storage/secattach/20260702/26727855.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727855.html Thu, 02 Jul 2026 16:13:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727809.html si-local-file:///var/storage/secattach/20260702/26727809.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727809.html Thu, 02 Jul 2026 16:11:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727809.html si-local-file:///var/storage/secattach/20260702/26727809.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01++Filed+by%3A+Shields+David+Stanley/26727809.html Thu, 02 Jul 2026 16:11:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01/26727776.html si-local-file:///var/storage/secattach/20260702/26727776.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01/26727776.html Thu, 02 Jul 2026 16:10:00 -0400 CV O.07041963 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01/26727776.html si-local-file:///var/storage/secattach/20260702/26727776.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CapsoVision%2C+Inc++++++++++For%3A+Jul+01/26727776.html Thu, 02 Jul 2026 16:10:00 -0400 CV O.07041963 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html <p>CapsoVision, Inc. (Nasdaq: CV) has appointed David S. Shields, M.D., to its board of directors, effective July 1, 2026, according to a company statement.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy, and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision since 2017.</p> <p>Dr. Shields previously held positions as assistant professor of medicine in the division of gastroenterology at Stanford University School of Medicine and director of endoscopy at Stanford Hospital. He has maintained a private gastroenterology consulting practice in Palo Alto, California, since http://www.streetinsider.com/Board+Changes/CapsoVision+adds+gastroenterologist+David+Shields+to+its+board/26727516.html Thu, 02 Jul 2026 16:05:13 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html <p>SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David S. Shields, M.D., to its Board of Directors, effective July 1, 2026.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision for nearly a decade. He succeeds Joanne C. Imperial, M.D., who has stepped down from the Board and will continue http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html Thu, 02 Jul 2026 16:05:00 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html <p>SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David S. Shields, M.D., to its Board of Directors, effective July 1, 2026.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision for nearly a decade. He succeeds Joanne C. Imperial, M.D., who has stepped down from the Board and will continue http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html Thu, 02 Jul 2026 16:05:00 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html <p>SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David S. Shields, M.D., to its Board of Directors, effective July 1, 2026.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision for nearly a decade. He succeeds Joanne C. Imperial, M.D., who has stepped down from the Board and will continue http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html Thu, 02 Jul 2026 16:05:00 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html <p>SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David S. Shields, M.D., to its Board of Directors, effective July 1, 2026.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision for nearly a decade. He succeeds Joanne C. Imperial, M.D., who has stepped down from the Board and will continue http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html Thu, 02 Jul 2026 16:05:00 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112 http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html <p>SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, announced the appointment of David S. Shields, M.D., to its Board of Directors, effective July 1, 2026.</p> <p>Dr. Shields is a board-certified gastroenterologist with more than 40 years of experience in academic medicine, clinical gastroenterology, advanced endoscopy and digestive disease management. He has served as a clinical advisor and consultant to CapsoVision for nearly a decade. He succeeds Joanne C. Imperial, M.D., who has stepped down from the Board and will continue http://www.streetinsider.com/Press+Releases/CapsoVision+Appoints+Gastroenterology+Leader+David+S.+Shields%2C+M.D.%2C+to+Board+of+Directors/26727494.html Thu, 02 Jul 2026 16:05:00 -0400 A.03295816 A.11608963 A.11955935 A.34833609 CV O.00983300 O.05010326 O.07041963 O.20558987 O.21533112